OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota modulation: a tool for the management of colorectal cancer
Yan Wang, Hui Li
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Interactive Relationships between Intestinal Flora and Bile Acids
Xiaohua Guo, Edozie Samuel Okpara, Wanting Hu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8343-8343
Open Access | Times Cited: 95

Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant
Rossella Salemi, Silvia Vivarelli, Daria Ricci, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 31

Gut Microbiota–Gut Metabolites and Clostridioides difficile Infection: Approaching Sustainable Solutions for Therapy
Bijay Gurung, Maranda Stricklin, Shaohua Wang
Metabolites (2024) Vol. 14, Iss. 1, pp. 74-74
Open Access | Times Cited: 14

Mechanisms of microbiota modulation: Implications for health, disease, and therapeutic interventions
Okechukwu Paul-Chima Ugwu, Esther Ugo Alum, Michael Ben Okon, et al.
Medicine (2024) Vol. 103, Iss. 19, pp. e38088-e38088
Open Access | Times Cited: 8

The footprint of gut microbiota in gallbladder cancer: a mechanistic review
Shujie Liu, Weijian Li, Jun Chen, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 7

Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 7

Effects of prebiotics, probiotics, and synbiotics on the prevention and treatment of cervical cancer: Mexican consensus and recommendations
Gabriela Gutiérrez Salmeán, Merari Delgadillo González, Ariadna Alejandra Rueda Escalona, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6

Epigenetics and environmental health
Min Zhang, Ting Hu, Tianyu Ma, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 4, pp. 571-596
Closed Access | Times Cited: 5

New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer
Zhipeng Li, Xiyang Ke, Zuo Dan, et al.
Nutrients (2022) Vol. 15, Iss. 1, pp. 48-48
Open Access | Times Cited: 22

Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota
Maohua Chen, Wei Lin, Nan Li, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 21

Gut microbiota resilience and recovery after anticancer chemotherapy
Sara Roggiani, Mariachiara Mengoli, Gabriele Conti, et al.
Microbiome Research Reports (2023) Vol. 2, Iss. 2, pp. 16-16
Open Access | Times Cited: 11

Exploring the Impact of Chemotherapy on the Emergence of Antibiotic Resistance in the Gut Microbiota of Colorectal Cancer Patients
Mutebi John Kenneth, Chin‐Chia Wu, Chuan‐Yin Fang, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 264-264
Open Access

The connection between epigenetics and gut microbiota‐current perspective
Xingxing Yuan, Yurong Tan, Ousman Bajinka, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 3

The impact of pre-, pro- and synbiotics supplementation in colorectal cancer treatment: a systematic review
Mariana Melo Moreira, M. Carriço, Manuel Luís Capelas, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3

Unveiling the overlooked fungi: the vital of gut fungi in inflammatory bowel disease and colorectal cancer
Yilin Huang, Yang Wang, Xiaotian Huang, et al.
Gut Pathogens (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3

Probiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment
Christina Thoda, Maria Touraki
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1898-1898
Open Access | Times Cited: 9

The potential role of gut microbiota outer membrane vesicles in colorectal cancer
Ran Meng, Minmin Zeng, Ying Ji, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 9

Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out
Gabriele Conti, Federica D’Amico, Marco Fabbrini, et al.
Genes (2022) Vol. 14, Iss. 1, pp. 55-55
Open Access | Times Cited: 12

Update on Mucoadhesive Approaches to target Drug Delivery in Colorectal Cancer
Neha Kanojia, Komal Thapa, Nitin Verma, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104831-104831
Closed Access | Times Cited: 6

Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer
Hanghang Yuan, Ruirui Gui, Zhicheng Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5

Identification of intestinal microbiome associated with lymph-vascular invasion in colorectal cancer patients and predictive label construction
Chuanbin Chen, Kang Chen, Zigui Huang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top